Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ANI Pharmaceuticals, Inc. - Common Stock
(NQ:
ANIP
)
66.10
+0.79 (+1.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ANI Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock
November 08, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
ANI Pharmaceuticals, Inc. Announces Pricing of $75 Million Public Offering of Common Stock
November 03, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
November 03, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
November 02, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
64 Biggest Movers From Yesterday
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
ANI Pharmaceuticals, inc (ANIP) Q3 2021 Earnings Call Transcript
November 01, 2021
ANIP earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates
November 01, 2021
ANI Pharmaceuticals Inc (NASDAQ: ANIP) has reported Q3 sales of $52.1 million, down 1.7% Y/Y, better than the consensus of $49.70 million. The company achieved an...
Via
Benzinga
Topics
Earnings
Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide
November 01, 2021
Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% to 15,525.52. The S&P, however, fell 0.10% to 4,600.81. The U.S. has the...
Via
Benzinga
Topics
Stocks
Dow, SPX Fall From Record Intraday Highs
November 01, 2021
Stocks are mixed at midday, with the Dow Jones Industrial Average reversing some of this morning's gains after briefly toppling the 36,000 level for the first time ever.
Via
Talk Markets
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today
November 01, 2021
The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel.
Via
The Motley Fool
Topics
Bankruptcy
Lawsuit
Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump
November 01, 2021
Midway through trading Monday, the Dow traded up 0.14% to 35,871.27 while the NASDAQ rose 0.23% to 15,534.49. The S&P also fell, dropping 0.03% to 4,603.98. The U.S. has the...
Via
Benzinga
Topics
Stocks
Ani Pharma Rockets After Winning FDA Approval To Revive Old Merck Drug
November 01, 2021
Cortophin Gel gained approval to treat several autoimmune conditions.
Via
Investor's Business Daily
40 Stocks Moving In Monday's Mid-Day Session
November 01, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the...
Via
Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
November 01, 2021
According to Benzinga Pro data, during Q3, ANI Pharmaceuticals (NASDAQ:ANIP) posted sales of $52.06 million. Earnings were up 77.1%, but ANI Pharmaceuticals still reported an...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views
November 01, 2021
Following the market opening Monday, the Dow traded up 0.08% to 35,846.72 while the NASDAQ rose 0.18% to 15,527.04. The S&P also fell, dropping 0.07% to 4,602.32. The U.S. has...
Via
Benzinga
Topics
Earnings
Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 01, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1...
Via
Benzinga
ANI Pharmaceuticals Reports Third Quarter 2021 Results
November 01, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome
November 01, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021
October 29, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...
Via
Benzinga
Earnings Scheduled For November 1, 2021
November 01, 2021
Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
September 20, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
September 17, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Looking Into ANI Pharmaceuticals's Return On Capital Employed
September 09, 2021
Benzinga Pro data, ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 sales of $48.62 million. Earnings fell to a loss of $15.55 million, resulting in a 610.77% decrease from last...
Via
Benzinga
ANI Pharma's Purified Cortrophin Gel Application Under FDA Review
August 31, 2021
The FDA has accepted ANI Pharmaceuticals Inc's (NASDAQ: ANIP) supplemental marketing application for Purified Cortrophin Gel. The application seeks approval...
Via
Benzinga
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome
August 31, 2021
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.